{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T16:04:17Z","timestamp":1649088257771},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00393-018-0489-3","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T06:23:14Z","timestamp":1528352594000},"page":"469-476","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Was der Rheumatologe vom Augenarzt lernen kann"],"prefix":"10.1007","volume":"77","author":[{"given":"M. D.","family":"Becker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Max","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dimitriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Saurenmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-M.","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Lortz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Grulich-Henn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,7]]},"reference":[{"issue":"Pt 3A","key":"489_CR1","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/eye.2000.84","volume":"14","author":"JM Benitez-Del-Castillo","year":"2000","unstructured":"Benitez-Del-Castillo JM, Garcia-Sanchez J, Iradier T et al (2000) Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis. Eye (Lond) 14(Pt 3A):340\u2013343","journal-title":"Eye (Lond)"},{"key":"489_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010469.pub2","author":"CJ Brady","year":"2016","unstructured":"Brady CJ, Villanti AC, Law HA et al (2016) Corticosteroid implants for chronic non-infectious uveitis. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.CD010469.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"489_CR3","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.preteyeres.2011.06.005","volume":"30","author":"MD Smet De","year":"2011","unstructured":"De Smet MD, Taylor SR, Bodaghi B et\u00a0al (2011) Understanding uveitis: the impact of research on visual outcomes. Prog Retin Eye Res 30:452\u2013470","journal-title":"Prog Retin Eye Res"},{"key":"489_CR4","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1007\/s00393-017-0360-y","volume":"76","author":"I Foeldvari","year":"2017","unstructured":"Foeldvari I, Walscheid K, Heiligenhaus A (2017) Uveitis bei juveniler idiopathischer Arthritis. Z\u00a0Rheumatol 76:664\u2013672","journal-title":"Z Rheumatol"},{"key":"489_CR5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ophtha.2003.06.014","volume":"111","author":"DC Gritz","year":"2004","unstructured":"Gritz DC, Wong IG (2004) Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology 111:491\u2013500 (discussion 500)","journal-title":"Ophthalmology"},{"key":"489_CR6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3899\/jrheum.080102","volume":"36","author":"E Jakob","year":"2009","unstructured":"Jakob E, Reuland MS, Mackensen F et\u00a0al (2009) Uveitis subtypes in a\u00a0german interdisciplinary uveitis center\u2014analysis of 1916 patients. J\u00a0Rheumatol 36:127\u2013136","journal-title":"J Rheumatol"},{"key":"489_CR7","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s00347-005-1302-7","volume":"103","author":"A L\u00f6sch","year":"2006","unstructured":"L\u00f6sch A, Flessa S, Fiehn C et\u00a0al (2006) Abkl\u00e4rung bei Uveitis: Kostenreduktion durch befundorientiertes diagnostisches Vorgehen. Ophthalmologe 103:512\u2013516","journal-title":"Ophthalmologe"},{"key":"489_CR8","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2017.1411518","author":"F Mackensen","year":"2017","unstructured":"Mackensen F, Heinz C, Jakob E et\u00a0al (2017) Randomized controlled study to evaluate the efficacy of adalimumab in patients with different forms of refractory uveitis. Ocul Immunol Inflamm. \n                    https:\/\/doi.org\/10.1080\/09273948.2017.1411518","journal-title":"Ocul Immunol Inflamm"},{"key":"489_CR9","first-page":"1277","volume":"30","author":"S Munoz-Fernandez","year":"2003","unstructured":"Munoz-Fernandez S, Hidalgo V, Fernandez-Melon J et al (2003) Sulfasalazine reduces the number of flares of acute anterior uveitis over a\u00a0one-year period. J\u00a0Rheumatol 30:1277\u20131279","journal-title":"J Rheumatol"},{"key":"489_CR10","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/S0140-6736(16)31339-3","volume":"388","author":"QD Nguyen","year":"2016","unstructured":"Nguyen QD, Merrill PT, Jaffe GJ et al (2016) Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a\u00a0multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Lancet 388:1183\u20131192","journal-title":"Lancet"},{"key":"489_CR11","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/acr.22848","volume":"68","author":"M Rudwaleit","year":"2016","unstructured":"Rudwaleit M, Rosenbaum JT, Landewe R et\u00a0al (2016) Observed incidence of uveitis following certolizumab pegol treatment in patients with axial spondyloarthritis. Arthritis Care Res 68:838\u2013844","journal-title":"Arthritis Care Res"},{"key":"489_CR12","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/s00393-017-0357-6","volume":"76","author":"M Rudwaleit","year":"2017","unstructured":"Rudwaleit M, Walscheid K, Heiligenhaus A (2017) Uveitis bei Spondyloarthritiden. Z\u00a0Rheumatol 76:682\u2013692","journal-title":"Z Rheumatol"},{"key":"489_CR13","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1002\/art.39667","volume":"68","author":"H Vallet","year":"2016","unstructured":"Vallet H, Seve P, Biard L et\u00a0al (2016) Infliximab versus adalimumab in the treatment of refractory inflammatory uveitis: a multicenter study from the French uveitis network. Arthritis Rheumatol 68:1522\u20131530","journal-title":"Arthritis Rheumatol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-018-0489-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-018-0489-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-018-0489-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T23:27:10Z","timestamp":1559863630000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-018-0489-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,7]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["489"],"URL":"https:\/\/doi.org\/10.1007\/s00393-018-0489-3","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,7]]},"assertion":[{"value":"7 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.D.\u00a0Becker, R.\u00a0Max, A.\u00a0Dimitriou, T.\u00a0Saurenmann, H.-M.\u00a0Lorenz, A.\u00a0Jansen, S.\u00a0Lortz, J.\u00a0Grulich-Henn und M.\u00a0Weber geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}